Drastich P, Lata J, Petrtyl J, Bruha R, Prochazka V, Vanasek T, Zdenek P, Skibova J, Hucl T, Spicak J

Idioma: Ingles.
Referencias bibliográficas: 26
Paginas: 142-149
Archivo PDF: 76.31 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices: Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective Multicenter Study. N Engl J Med 1988; 319: 983-9.

2. D‘Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-54.

3. De Franchis R. Endoscopy critics vs. endoscopy enthusiasts for primary prophylaxis of variceal bleeding. Hepatology 2006; 43: 24-6.

4. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, Pandya P, et al: Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-9.

5. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991; 324: 1532-8.

6. Pagliaro L, D’Amico G, Sörensen TI, Lebrec D, Burroughs AK, Morabito A, Tiné F, et al: Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of non surgical treatment. Ann Intern Med 1992; 117:59-70

7. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Lebrec D: Prevention of gastrointestinal bleeding in cirrhosis (letter). N Engl J Med 1991; 325: 1517.

8. Feu F, García-Pagán JC, Bosch J, Luca A, Terés J, Escorsell A, Rodés J. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995; 346: 1056-9.

9. Lee SS, Braillon A, Girod C, Geoffroy P, Lebrec D: Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats. J Hepatol 1986; 3: 38-41.

10. Bosch J, García-Pagán JC: Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000; 32(Suppl. 1):141-56.

11. Sharara AI, Rockey DC: Gastroesophageal variceal hemorrhage. N Engl J Med 2001; 345: 669-81.

12. The Veterans Affairs Cooperative Variceal Sclerotherapy Group: Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver disease. A randomized, singleblind, multicenter clinical trial. N Engl J Med 1991; 324: 1779-84

13. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. Hepatology 2001; 33: 802-7.

14. De BK, Ghoshal UC, Das T, Santra A, Biswas PK: Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999; 14: 220-4.

15. Lui HF, Stanley AJ, Forrest EH, Jalan R, Hislop WS, Mills PR, Finlayson ND, et al. Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002; 123: 735-44.

16. Schepke M, Kleber G, Nürnberg D, Willert J, Koch L, Veltzke- Schlieker W, Hellerbrand C, et al. Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2004; 40: 65-72.

17. Thuluvath PJ, Maheshwari A, Jagannath S, Arepally A: A randomized controlled trial of beta-blockers versus endoscopic band ligation for primary prophylaxis: a large sample size is required to show a difference in bleeding rates. Dig Dis Sci 2005; 50: 407-10.

18. Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, Cheng JS, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004; 59: 333-8.

19. Lay CS, Tsai YT, Lee FY, Lai YL, Yu CJ, Chen CB, Peng CY: Endoscopic variceal ligation versus propranolol in prophylaxis of first variceal bleeding in patients with cirrhosis. J Gastroenterol Hepatol 2006; 21: 413-9.

20. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS: Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999; 340: 988-93.

21. Jutabha R, Jensen DM, Martin P, Savides T, Han SH, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high-risk esophageal varices. Gastroenterology 2005; 128: 870-81.

22. Triantos C, Vlachogiannakos J, Armonis A, Saveriadis A, Kougioumtzian A, Leandro G, Manolakopoulos S, et al: Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Aliment Pharmacol Ther 2005; 21: 1435-43.

23. Perez-Ayuso RM, Valderrama S, Espinoza M, Rollán A, Sánchez R, Otarola F, Medina B, et al. Endoscopic band ligation versus propranolol for the primarry prophylaxis of variceal bleeding in cirrhotic patients with high risk esophageal varices. Ann Hepatol 2010; 9: 15-22.

24. De Franchis R: Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005; 43: 167-76.

25. Whitehead A. Meta-Analysis of controlled clinical trials. England: John Wiley; 2002.

26. Pereira-Lima JC, Zanette M, Lopes CV, de Mattos AA: The influence of endoscopic variceal ligation on portal pressure gradient in cirrhotics. Hepatogastroenterology 2003; 50: 102-6.